ENvue Medical Expands Hospital Footprint, Eyes Pediatric and At-Home Growth
Event summary
- ENvue Navigation Platform now deployed in 40 U.S. hospitals, up from 39 in early 2026
- USPTO issued Notice of Allowance for patent covering feeding tube with integrated electromagnetic navigation and distal-tip camera
- Launched ENFit Syringe line through U-Deliver partnership for at-home enteral care
- PainShield® and UroShield® added to UK National Health Service Drug Tariff Part IX
- Appointed Marc Waldman as Vice President, Commercial in January 2026
The big picture
ENvue Medical is positioning itself as a dual-platform medtech player, combining hospital-based navigation systems with at-home therapeutic devices. The company's focus on reducing blind feeding tube placements aligns with hospital pressures for cost efficiency and patient safety. With 13 million annual procedures in the U.S., ENvue's technology addresses a significant clinical need while creating recurring revenue streams through consumable feeding tubes.
What we're watching
- Hospital Adoption
- Whether ENvue can sustain its 40-hospital deployment growth pace through 2026
- Regulatory Milestones
- The pace at which pediatric and PICC line indications advance through clinical validation
- Revenue Diversification
- How quickly at-home enteral solutions scale through U-Deliver partnership
Related topics